Monotherapy update from Phase 1 portion in Phase1/2 trial of the menin-MLL inhibitor enzomenib (DSP-5336) in patients with relapsed or refractory acute leukemia


Por: Daver, N, Zeidner, J, Watts, J, Yuda, J, Levis, M, Montesinos, P, Papayannidis, C, Fukushima, K, Shima, T, Raffoux, E, Borate, U, Palmisiano, N, Brandwein, J, Heiblig, M, Miyazaki, Y, Ikezoe, T, Ooi, M, Wu, SJ, Wang, E, Vives, S, Strickland, S, Breems, D, Hosono, TN, Ogawa, Y, Onodera, K, Brunner, A, Keiffer, G, Pardee, T, Shami, P, Eghtedar, A, Cai, HL, Xu, B, Robson, P, Watanabe, A, Hitron, M, Shah, J, Kantarjian, H and Erba, H

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Daver, N:
 Univ Texas MD Anderson Canc Ctr, Houston, TX USA

Zeidner, J:
 Univ North Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

Watts, J:
 Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA

Yuda, J:
 Natl Canc Ctr Hosp East, Kashiwa, Japan

Levis, M:
 Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

Montesinos, P:
 Hosp Univ & Politecn La Fe, Valencia, Spain

Papayannidis, C:
 Ist Ematol Seragnoli, IRCCS Azienda Osped Univ Bologna, Bologna, Italy

Fukushima, K:
 Univ Osaka, Grad Sch Med, Suita, Japan

Shima, T:
 Kyushu Univ, Grad Sch Med Sci, Fukuoka, Japan

Raffoux, E:
 St Louis Univ Hosp, AP HP Paris, Inst Leucemie St Louis, Paris, France

Borate, U:
 Ohio State Univ, Columbus, OH USA

Palmisiano, N:
 Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

Brandwein, J:
 Univ Alberta, Edmonton, AB, Canada

Heiblig, M:
 Hosp Civils Lyon, Lyon, France

Miyazaki, Y:
 Nagasaki Univ Hosp, Nagasaki, Japan

Ikezoe, T:
 Fukushima Med Univ, Fukushima, Japan

Ooi, M:
 Natl Univ, Canc Inst, Singapore, Singapore

Wu, SJ:
 Natl Taiwan Univ Hosp, Taipei, Taiwan

Wang, E:
 Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

:
 Hosp Germans Trias i Pujol, Inst Catala Oncol Badalona, Badalona, Spain

Strickland, S:
 TriStar Centennial, SCRI, Nashville, TN USA

Breems, D:
 Ziekenhuis Stroom, Antwerp, Belgium

Hosono, TN:
 Univ Fukui, Fukui, Japan

Ogawa, Y:
 Tokai Univ, Sch Med, Kanagawa, Japan

Onodera, K:
 Tohoku Univ, Grad Sch Med, Sendai, Japan

Brunner, A:
 Massachusetts Gen Hosp, Boston, MA USA

Keiffer, G:
 Thomas Jefferson Univ, Sidney Kimmel Comprehens Canc Ctr, Philadelphia, PA USA

Pardee, T:
 Atrium Hlth Wake Forest Baptist, Comprehens Canc Ctr, Winston Salem, NC USA

Shami, P:
 Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

Eghtedar, A:
 Colorado Blood Canc Inst, Denver, CO USA

Cai, HL:
 Sumitomo Pharm Amer, Marlborough, MA USA

Xu, B:
 Sumitomo Pharm Amer, Marlborough, MA USA

Robson, P:
 Sumitomo Pharm Amer, Marlborough, MA USA

Watanabe, A:
 Sumitomo Pharm Amer, Marlborough, MA USA

Hitron, M:
 Sumitomo Pharm Amer, Marlborough, MA USA

Shah, J:
 Sumitomo Pharm Amer, Marlborough, MA USA

Kantarjian, H:
 Sumitomo Pharm Amer, Marlborough, MA USA

Erba, H:
 Duke Canc Inst, Durham, NC USA
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 763-764
WOS Id: 001659229600015

MÉTRICAS